July 27, 2011 -- Boston Scientific Corporation, the cardiovascular medical device maker, announced plans to spend $150 million over the next five years to increase its China presence. Specifically, the company will build a manufacturing facility in the PRC to serve local markets, and it will also establish a training center, complete with virtual learning systems, to teach the latest procedures. At the end of the five years, Boston Scientific expects its China operations to be producing $500 million in revenue each year. More details....
Stock Symbol: (NYSE: BSX)
